DataMEDS AI (MEDS) Financials: Revenue & Earnings
$9.96M
Market Cap
-0.05
P/E
—
Forward P/E
29
Score
MEDS price $2.22 +0.16 +7.67%
Stocklytics score rationale: value 59, quality 28, growth 0.
| 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|
| 32777728 | 0 | 18128831 | 23337860 |
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
MEDS fair value Not meaningful. Price $2.22.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-08-17 | -3.26 | — | 1.78M | — |
| 2026-05-19 | -3.50 | — | 1.56M | — |
| 2026-03-20 | -6.50 | — | 1.67M | — |
| 2025-11-19 | -0.44 | — | 3.01M | — |
| 2025-08-19 | -0.11 | — | 7.79M | — |
| 2025-05-12 | -0.62 | — | 10.86M | — |
| 2025-03-26 | -0.08 | — | -16.05M | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-22 | AJJARAPU SURENDRA K | Buy | 100.00K | $0.01 | 500 |
| 2026-06-22 | AJJARAPU SURENDRA K | Buy | 100.00K | $0.01 | 500 |
| 2026-06-22 | Patel Prashant | Buy | 100.00K | $0.01 | 500 |
| 2026-06-22 | Patel Prashant | Buy | 100.00K | $0.01 | 500 |
| 2026-03-31 | Patel Prashant | Buy | 5.00M | $0.00 | 500 |
| 2026-03-31 | AJJARAPU SURENDRA K | Buy | 5.00M | $0.00 | 500 |
| 2026-03-31 | Patel Prashant | Buy | 5.00M | $0.20 | 1.00M |
| 2026-03-31 | Patel Prashant | Buy | 5.00M | $0.01 | 50.00K |
| 2026-03-31 | AJJARAPU SURENDRA K | Buy | 5.00M | $0.20 | 1.00M |
| 2026-03-31 | AJJARAPU SURENDRA K | Buy | 5.00M | $0.01 | 50.00K |
| 2026-03-19 | Velez Marlene | Other | 0 | — | — |
| 2026-02-04 | Herman Gary L | Other | 0 | — | — |
| 2025-10-07 | Sherb Eric Michael | Other | 0 | — | — |
| 2025-10-02 | Doss Howard A. | Other | 0 | — | — |
| 2025-10-02 | Fell Donald G. | Other | 0 | — | — |
| 2025-10-02 | Lee Steven Dale | Other | 0 | — | — |
| 2025-07-02 | PETERSON MICHAEL L | Sell | 200.00K | $0.90 | 180.00K |
| 2025-04-10 | PETERSON MICHAEL L | Other | 0 | — | — |
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
DataMEDS AI, Inc. (MEDS) trades at $2.22, with a market cap of $9.96M and a trailing P/E of -0.05. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
| 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|
| 32777728 | 0 | 18128831 | 23337860 |
Insights · Dividends · Forecast · Financials · Learn
$9.96M
Market Cap
-0.05
P/E
—
Forward P/E
29
Score